IL-1β and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases

Immunobiology

Volumn 218, Issue 3, 2013, Pages 285-291

  Rebuffat, Sandra A ^a,c   Kammoun Krichen, Maha ^b,c   Charfeddine, Ilhem ^d   Ayadi, Hammadi ^b,c   Bougacha Elleuch, Noura ^b,c   Peraldi Roux, Sylvie ^a,c  

^a EA7288   (France)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c CNRS   (France)

^d HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Autoimmune thyroid diseases; Junction complex; Pro inflammatory cytokines; Tight junction

Indexed keywords

CLAUDIN; INTERLEUKIN 1BETA; JUNCTIONAL ADHESION MOLECULE A; MEMBRANE PROTEIN; PROTEIN ZO1; THYROTROPIN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; CELL MEMBRANE; CELLULAR DISTRIBUTION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THYROID DISEASE; THYROID EPITHELIUM TIGHTNESS; THYROID FOLLICLE CELL; THYROID FUNCTION; TIGHT JUNCTION; WESTERN BLOTTING;

CELL ADHESION MOLECULES; CELL MEMBRANE; CELLS, CULTURED; CLAUDINS; EPITHELIUM; GENE EXPRESSION REGULATION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-1BETA; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; THYROID GLAND; THYROTROPIN; TIGHT JUNCTIONS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84873108617     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.016     Document Type: Article

References (25)

1. Chiovato L., Bassi P., Santini F., Mammoli C., Lapi P., Carayon P., Pinchera A. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 1993, 77:1700-1705.
2. Del Maschio A., De Luigi A., Martin-Padura I., Brockhaus M., Bartfai T., Fruscella P., Adorini L., Martino G., Furlan R., De Simoni M.G., Dejana E. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 1999, 190:1351-1356.
3. Estienne V., Duthoit C., Reichert M., Praetor A., Carayon P., Hunziker W., Ruf J. Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J. 2002, 16:1087-1092.
4. Ewert P., Aguilera S., Alliende C., Kwon Y.J., Albornoz A., Molina C., Urzúa U., Quest A.F., Olea N., Pérez P., Castro I., Barrera M.J., Romo R., Hermoso M., Leyton C., González M.J. Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum. 2010, 62:1280-1289.
5. Gianoukakis A., Douglas R.S., King C.S., Cruikshank W.W., Smith T.J. Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 2006, 147:1941-1949.
6. Gretzer C., Thomsen P., Jansson S., Nilsson M. Co-culture of human monocytes and thyrocytes in bicameral chamber: monocyte-derived IL-1alpha impairs the thyroid epithelial barrier. Cytokine 2000, 12:32-40.
7. Guo J., Jaume J.C., Rapoport B., McLachlan S.M. Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J. Clin. Endocrinol. Metab. 1997, 82:925-931.
8. Kammoun-Krichen M., Bougacha-Elleuch N., Makni K., Rebai M., Peraldi-Roux S., Rebai A., Mnif M., Abid M., Jouida J., Ayadi H. Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur. Cytokine Netw. 2007, 18:196-200.
9. Madara J.L. Loosening tight junctions. Lessons from the intestine. J. Clin. Invest. 1989, 83:1089-1094.
10. Madara J.L., Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 1989, 83:724-727.
11. Metcalfe R.A., Oh Y.S., Stroud C., Arnold K., Weetman A.P. Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease. Autoimmunity 1997, 25:65-72.
12. Mullin J.M., Kofeldt L.M., Russo L.M., Hagee M.M., Dantzig A.H. Basolateral 3-O-methylglucose transport by cultured kidney (LLC-PK1) epithelial cells. Am. J. Physiol. 1992, 262:F480-F487.
13. Nilsson M., Husmark J., Bjorkman U., Ericson L.E. Cytokines and thyroid epithelial integrity: interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J. Clin. Endocrinol. Metab. 1998, 83:945-952.
14. Nilsson M., Husmark J., Nilsson B., Tisell L.E., Ericson L.E. Primary culture of human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Eur. J. Endocrinol. 1996, 135:469-480.
15. Ozaki H., Ishii K., Horiuchi H., Arai H., Kawamoto T., Okawa K., Iwamatsu A., Kita T. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 1999, 163:553-557.
16. Parkes A.B., Othman S., Hall R., John R., Richards C.J., Lazarus J.H. The role of complement in the pathogenesis of postpartum thyroiditis. J. Clin. Endocrinol. Metab. 1994, 79:395-400.
17. Rebuffat S.A., Nguyen B., Robert B., Castex F., Peraldi-Roux S. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 2008, 93:929-934.
18. Rodien P., Madec A.M., Ruf J., Rajas F., Bornet H., Carayon P., Orgiazzi J. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J. Clin. Endocrinol. Metab. 1996, 81:2595-2600.
19. Shaw S., Perkins B.N., Lim Y.C., Liu Y., Nusrat A., Schnell F.J., Parkos C.A., Luscinskas F.W. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am. J. Pathol. 2001, 159:2281-2291.
20. Tamm I., Cardinale I., Krueger J., Murphy J.S., May L.T., Sehgal P.B. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med. 1989, 170:1649-1669.
21. Tedelind S., Ericson L.E., Karlsson J.O., Nilsson M. Interferon-gamma down-regulates claudin-1 and impairs the epithelial barrier function in primary cultured human thyrocytes. Eur. J. Endocrinol. 2003, 149:215-221.
22. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2001, 2:285-293.
23. Tsukita S., Yamazaki Y., Katsuno T., Tamura A., Tsukita S. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008, 27:6930-6938.
24. Weetman A.P. The potential immunological role of the thyroid cell in autoimmune thyroid disease. Thyroid 1994, 4:493-499.
25. Weetman A.P., Bright-Thomas R., Freeman M. Regulation of interleukin-6 release by human thyrocytes. J. Endocrinol. 1990, 127:357-361.